Union members who assemble Boeing's fighter jets in the St. Louis area have “overwhelmingly voted” to reject the company's contract offer on Sunday, with the company now preparing for an imminent strike.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of purchasers of securities of Vestis Corporation (NYSE: VSTS) between May 2, 2024 and May 6, 2025. Vestis provides uniform rentals and workplace supplies across the United States and Canada. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of KBR, Inc. (“KBR” or the “Company”) (NYSE: KBR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

ATLANTA, July 28, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Fortrea Holdings, Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information about Fortrea's business, operations, and prospects, including allegations that: (i) Fortrea overestimated the amount of revenue the Pre-Spin Projects were likely to contribute to the Company's 2025 earnings; (ii) Fortrea overstated the cost savings it would likely achieve by exiting the transition services agreements; (iii) as a result, Fortrea's previously announced EBITDA targets for 2025 were inflated; …

U.S. equities were mhigher at midday after President Donald Trump and European Commission President Ursula von der Leyen announced a new trade agreement between the U.S. and the European Union. The Dow Jones Industrial Average, Nasdaq, and S&P 500 all rose.

Ebrahim Poonawala, BofA Securities senior North America banks analyst, joins 'Money Movers' to discuss bank earnings and the 'Mag 5' of banking.

$5.0 million upfront with up to an additional $10.0 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants

The strategy of buying and holding a couple of high-conviction investments for the long-term has a lot of merit to it. For long-term buy-and-hold, I prioritize assets with durable moats, strong management, and exposure to enduring growth trends. I discuss my 2 favorite buy and hold "forever" investments right now.

With one of the world's biggest innovators about to release its second-quarter earnings report on Wednesday, traders from opposing sides will eagerly await the results. Wall Street analysts are looking for social media giant and tech juggernaut Meta Platforms Inc. META to deliver earnings per share (EPS) of $5.86 on revenue of $44.58 billion.

Sale reflects NEOGOV's industry-leading position in purpose-built government HR and compliance software solutions, providing an essential service to public-sector agencies NEW YORK , July 28, 2025 /PRNewswire/ -- Funds managed by Warburg Pincus LLC, the pioneer of global growth investing, and global investment firm Carlyle (NASDAQ: CG) today announced the signing of a definitive agreement to sell NEOGOV ("the Company"),a provider of HR and compliance software for U.S. public sector agencies, to EQT X fund ("EQT") and Canada Pension Plan Investment Board ("CPP Investments"). Founded in 2000 and headquartered in El Segundo, California, NEOGOV delivers purpose-built human capital management and …

The United States smartphone market grew just 1% in the second quarter as vendors front-loaded device inventories amid tariff concerns, while supply chain negotiations between China and the United States boosted shipments of Indian-made phones, research firm Canalys said on Monday.

CoreWeave's stock (CRWV) is currently extremely oversold and its estimated FY2026 forward P/S ratio is comparable to a mature company like J&J. The company is projected to more than quadruple its revenue in less than five years, which means its forward P/S ratio for next year should be significantly higher. CRWV recently got 'Buy' rating from highly reputable Argus Research with a $200 target price.

ABBV's Q2 results are likely to hinge on Skyrizi and Rinvoq growth as Humira declines, with 2025 set for a strong revenue rebound.

SFM eyes a strong Q2, with 30.9% EPS growth expected, but its high valuation raises questions ahead of earnings.

Heavy-Duty Earnings Week Commences.

Sensient Technologies has seen a sharp share price rally, driven by hopes for regulatory tailwinds and healthier food trends, despite modest operational improvements. Recent earnings and sales growth are solid but not spectacular, with valuation multiples now stretched to 33-34x earnings after the stock's 50% surge. The business could benefit from stricter regulations on artificial ingredients, but the impact and timing remain uncertain, making me cautious at current levels.

RHI beats Q2 estimates but posts lower earnings and revenues, with Talent Solutions weakness leading to a 6.1% stock drop.

Tempus AI and Recursion Pharmaceuticals are fine ways to play the AI revolution from the health angle.

Alibaba Group (NYSE:BABA) has unveiled its first smart glasses, marking the e-commerce giant's entry into the growing wearable technology market and stepping up competition with rivals like Meta and Xiaomi. The Quark AI Glasses, introduced at the World Artificial Intelligence Conference (WAIC) in Shanghai, are powered by Alibaba's proprietary Qwen large language model and Quark AI assistant.

Macro uncertainty remains a concern, but growing global connectivity needs could drive prospects for the Zacks Satellite and Communication industry participants like GSAT, IRDM and GILT.